학술논문
Role of BCL2L10 methylation and TET2 mutations in higher risk myelodysplastic syndromes treated with 5-azacytidine.
Document Type
Letter
Author
Source
Subject
*LETTERS to the editor
*METHYLATION
*AZACITIDINE
*THERAPEUTIC use of antimetabolites
*THERAPEUTIC use of antineoplastic agents
*PROTEINS
*MYELODYSPLASTIC syndromes
*SURVIVAL
*RESEARCH
*GENETIC mutation
*RESEARCH methodology
*PROGNOSIS
*RETROSPECTIVE studies
*MEDICAL cooperation
*EVALUATION research
*DNA methylation
*COMPARATIVE studies
*DNA-binding proteins
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
Language
ISSN
0887-6924
Abstract
A letter to the editor is presented which discusses the prognostic role of TET2 mutations BCL2L10 methylation profiling on patients with high risk of myelodysplastic syndrome with 5-azacytidine.